S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Avoro Capital Advisors/Q3 2023

Avoro Capital Advisors

Period: Q3 2023 Β· Filed: 2023-11-14
View on SEC EDGAR β†—
AUM
$6.41B
Total portfolio value
Positions
46
Reported securities
Top Holding
HZNP
12.6% $809.8M
QoQ Changes
+8 / -5
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2023-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
HZNPHORIZON THERAPEUTICS PLC$809.8M12.63%β€”β€”
12.6%
UTHRUNITED THERAPEUTICS CORP$644.3M10.05%$222.14$555.91+150.3%
10.1%
ARGXARGENX SE$491.6M7.67%$487.32$939.68+92.8%
7.7%
SRPTSAREPTA THERAPEUTICS INC$487.9M7.61%$118.59$19.28-83.7%
7.6%
APLSAPELLIS PHARMACEUTICALS INC$422.7M6.59%$37.14β€”
6.6%
SGENSEAGEN INC$373.3M5.82%β€”β€”
5.8%
ASNDASCENDIS PHARMA$343.7M5.36%$91.13$274.50+201.2%
5.4%
BMRNBIOMARIN PHARMACEUTICAL INC$340.6M5.31%$87.08$58.99-32.3%
5.3%
FOLDAMICUS THERAPEUTICS INC$333.2M5.20%β€”β€”
5.2%
KRYSKRYSTAL BIOTECH INC$297.6M4.64%$111.57$375.07+236.2%
4.6%
MRTXMIRATI THERAPEUTICS INC$290.4M4.53%β€”β€”
4.5%
MDGLMADRIGAL PHARMACEUTICALS INC$227.1M3.54%$143.36$528.10+268.4%
3.5%
ALNYALNYLAM PHARMACEUTICALS INC$179.1M2.79%$178.96$312.78+74.8%
2.8%
XENEXENON PHARMACEUTICALS INC$167.4M2.61%$33.06$60.96+84.4%
2.6%
CBAYCYMABAY THERAPEUTICS INC$153.6M2.40%β€”β€”
2.4%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$114.0M1.78%$57.58$18.95-67.1%
1.8%
BCRXBIOCRYST PHARMACEUTICALS INC$81.8M1.28%$6.77$9.84+45.4%
1.3%
ROIVROIVANT SCIENCES LTD$54.3M0.85%$10.52$35.13+233.9%
0.8%
KYMRKYMERA THERAPEUTICS INC$53.6M0.84%$13.57$113.51+736.5%
0.8%
RAREULTRAGENYX PHARMACEUTICAL INC$53.5M0.83%$34.80$33.47-3.8%
0.8%
GPCRSTRUCTURE THERAPEUTICS INC$50.4M0.79%$56.60$53.45-5.6%
0.8%
NUVLNUVALENT INC$37.4M0.58%$45.81$123.73+170.1%
0.6%
MNKDMANNKIND CORP$37.2M0.58%$4.03$4.52+12.2%
0.6%
SNDXSYNDAX PHARMACEUTICALS INC$37.1M0.58%$13.50$21.82+61.6%
0.6%
IOVAIOVANCE BIOTHERAPEUTICS INC$30.5M0.48%$4.43$4.31-2.7%
0.5%
AKROAKERO THERAPEUTICS ORD$28.1M0.44%β€”β€”
0.4%
KURAKURA ONCOLOGY INC$27.2M0.42%$8.60$11.10+29.1%
0.4%
RCKTROCKET PHARMACEUTICALS INC$25.6M0.40%$19.45$3.84-80.3%
0.4%
MRNSMARINUS PHARMACEUTICALS INC$25.4M0.40%β€”β€”
0.4%
TNGXTANGO THERAPEUTICS INC$25.0M0.39%$11.25$29.46+161.9%
0.4%

Quarter-on-Quarter Activity

Q3 2023 vs. Q2 2023

New Positions (8)

TickerIssuerNotionalSince Filing
GPCRSTRUCTURE THERAPEUTICS INC$50.4M-5.6%
AKROAKERO THERAPEUTICS ORD$28.1M
RCKTROCKET PHARMACEUTICALS INC$25.6M-80.3%
CERECEREVEL THERAPEUTICS HLDNG$20.9M
TSHATAYSHA GENE THERAPIES INC$12.4M
MRUSMERUS N V$10.5M
QQQPUTInvesco QQQ Trust$1.2M
SYREAEGLEA BIOTHERAPEUTICS INC$0.1M

Exited Positions (5)

TickerIssuerNotional
ISEEIVERIC BIO INC$316.7M
DICEDICE THERAPEUTICS INC$102.2M
DSGNDESIGN THERAPEUTICS INC$22.1M
MRSNMERSANA THERAPEUTICS INC$21.0M
AGLEAEGLEA BIOTHERAPEUTICS INC$0.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
RAREULTRAGENYX PHARMACEUTICAL INC$18.9M+100.0%-3.8%
ARWRARROWHEAD PHARMACEUTICALS INC$2.4M+58.1%
TNGXTANGO THERAPEUTICS INC$19.6M+35.5%+161.9%
MRTXMIRATI THERAPEUTICS INC$89.7M+20.0%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$26.0M+15.9%-67.1%
MDGLMADRIGAL PHARMACEUTICALS INC$-122.9M+2.6%+268.4%
ASNDASCENDIS PHARMA$24.1M+2.5%+201.2%
KRYSKRYSTAL BIOTECH INC$-3.0M+0.2%+236.2%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
NUVLNUVALENT INC$-30.1M-49.2%+170.1%
ARGXARGENX SE$-0.8M-20.9%+92.8%
ROIVROIVANT SCIENCES LTD$-4.2M-19.9%+233.9%
SRPTSAREPTA THERAPEUTICS INC$-42.1M-13.0%-83.7%
ALNYALNYLAM PHARMACEUTICALS INC$-30.8M-8.5%+74.8%
BCRXBIOCRYST PHARMACEUTICALS INC$-3.1M-4.2%+45.4%
KURAKURA ONCOLOGY INC$-5.7M-4.0%+29.1%
BMRNBIOMARIN PHARMACEUTICAL INC$-6.1M-3.8%-32.3%
← Back to Hedge Funds